Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR)

被引:11
|
作者
Sanchis-Gomar, Fabian [1 ]
Bonaguri, Chiara [2 ]
Pareja-Galeano, Helios [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Candel, Jorge [3 ]
Vina, Jose [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,INCLIVA, Valencia 46010, Spain
[2] Univ Parma, Azienda Osped, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43100 Parma, Italy
[3] Valencia CF Med Serv, Valencia, Spain
关键词
physical exercise; soluble urokinase plasminogen activator receptor; suPAR; allopurinol; EXHAUSTIVE PHYSICAL-EXERCISE; MORTALITY; TOUR;
D O I
10.7754/Clin.Lab.2012.120728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although physical exercise acutely increases the most widely used inflammatory biomarkers, there is no information on its effect on soluble urokinase plasminogen activating receptor (suPAR), a circulating biomarker increasingly used for the assessment of systemic inflammation. Methods: suPAR was assessed with the quantitative suPARnostic (R) Standard ELISA Assay (Virogates, Birkerod, Denmark) in 12 professional football players before and after a football match. The athletes were divided into two experimental groups. An oral dose of 300 mg of allopurinol was administered to one group of six participants four hours before a match; the other six participants received placebo. Results: Serum suPAR concentration did not vary significantly after the match in both the placebo and allopurinol group. No significant differences were observed between placebo and allopurinol groups at baseline and after the game. Conclusions: At variance with other consolidated inflammatory biomarkers, suPAR is not influenced by either physical exercise or administration of xanthine oxidase inhibitors.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [31] The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection
    Aslan, Sevinc
    Demirdal, Tuna
    Erbak, Huriye
    Aslan, Cem
    INFECTIOUS DISEASES, 2020, 52 (02) : 107 - 113
  • [32] Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis
    Yilmaz, Huriye Erbak
    Aksun, Saliha
    Gunay, Sueleyman
    Elmali, Ferhan
    Cekic, Cem
    ARAB JOURNAL OF GASTROENTEROLOGY, 2023, 24 (03) : 175 - 179
  • [33] Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
    Phuong Anh Le Thy
    Thuy Yen Hoang Thi
    Kiem Hao Tran
    Huu Son Nguyen
    EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE, 2022, 70 (01)
  • [34] Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
    Lippi, Giuseppe
    Henry, Brandon M.
    Favaloro, Emmanuel J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (11) : E413 - E415
  • [35] The value of urinary soluble urokinase plasminogen activator receptor (suPAR) in children with nephrotic syndrome
    Phuong Anh Le Thy
    Kiem Hao Tran
    Thuy Yen Hoang Thi
    Minh Phuong Phan Thi
    Huu Son Nguyen
    AIMS MEDICAL SCIENCE, 2021, 8 (02): : 163 - 174
  • [36] SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) DETERMINES OUTCOMES IN CLINICAL AND EXPERIMENTAL SEPTIC ACUTE KIDNEY INJURY
    Nusshag, Christian
    Wei, Changli
    Hahm, Eunsil
    Szudarek, Roman
    Kaelble, Florian
    Speer, Claudius
    Uhle, Florian
    Eugen-Olsen, Jesper
    Weigand, Markus A.
    Zeier, Martin
    Morath, Christian
    Brenner, Thorsten
    Reiser, Jochen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [37] Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure
    Koch, Alexander
    Zimmermann, Henning W.
    Gassler, Nikolaus
    Jochum, Christoph
    Weiskirchen, Ralf
    Bruensing, Jan
    Buendgens, Lukas
    Dueckers, Hanna
    Bruns, Tony
    Gerken, Guido
    Neumann, Ulf P.
    Adams, David H.
    Trautwein, Christian
    Canbay, Ali
    Tacke, Frank
    LIVER INTERNATIONAL, 2014, 34 (09) : 1330 - 1339
  • [38] Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia
    T. Mölkänen
    E. Ruotsalainen
    C. W. Thorball
    A. Järvinen
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 1417 - 1424
  • [39] Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease
    Kolho, Kaija-Leena
    Valtonen, Elsa
    Rintamaki, Hanne
    Savilahti, Erkki
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (8-9) : 951 - 955
  • [40] Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Joyce, Jessica
    Cabanas, Noel
    Pisharody, Rohan
    Ouyang, Bichun
    Patel, Roshni
    Reiser, Jochen
    Hall, Deborah A.
    Witek, Natalie
    PARKINSONISM & RELATED DISORDERS, 2022, 101 : 39 - 42